RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.
Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, Silverman RH, Witte JS.
Casey G, et al. Among authors: witte js.
Nat Genet. 2002 Dec;32(4):581-3. doi: 10.1038/ng1021. Epub 2002 Nov 4.
Nat Genet. 2002.
PMID: 12415269